EUROPE COUGH SYRUP MARKET FORECAST 2023-2032

The Europe cough syrup market growth evaluation includes the assessment of Poland, Germany, Italy, Spain, France, the United Kingdom, Belgium, and Rest of Europe. In the United Kingdom, cough, cold, and sore throat products, for instance, experienced a substantial 36 percent boost in sales in 2022. This surge in sales reflects the growing preference among UK consumers for self-management of common health issues, leading to increased consumption of non-prescription remedies.

Among these non-prescription options, cough syrups have emerged as the preferred choice for individuals seeking relief from cough and related symptoms. The ease of purchasing these syrups from local pharmacies and retail outlets plays a significant role in their popularity. Additionally, the wide range of over-the-counter cough and cold medications available in the UK market often includes cough syrups specifically formulated to address particular symptoms, such as dry or chesty coughs.

Furthermore, the contrast in regulatory policies regarding codeine-containing cough syrups between France, where they are available over the counter (OTC), and the United States, where a prescription is mandatory, is expected to exert a substantial influence on the France cough syrup market. This variation in accessibility grants French consumers a distinctive advantage, affording them more convenience and independence when it comes to addressing their cough and associated symptoms.

The Europe cough syrup market segmentation includes distribution channel, age group, and product type. The distribution channel segment includes hospital pharmacies, e-pharmacies, and retail pharmacies.

While less prevalent than retail pharmacies, hospital pharmacies play a crucial role in the distribution of cough syrups within various healthcare settings. Their primary focus is on serving patients within the hospital or healthcare facility. Their primary responsibility is managing the pharmaceutical needs of inpatients, ensuring they receive prescribed medications, including cough syrups, as part of their treatment plans. This direct provision within the hospital environment guarantees patient access to specific medicines prescribed by their healthcare providers.

Hospital pharmacies also have a significant role in maintaining medication safety and ensuring quality control. They strictly adhere to regulations and standards, ensuring proper storage, preparation, and dispensing of cough syrups and other medications. This dedication to safety is crucial in preventing medication errors and adverse reactions, especially in hospital settings where patients may be taking multiple medications.

Some of the eminent companies in the Europe cough syrup market are Abbott Laboratories, Acella Pharmaceuticals, Novartis AG, Pfizer Inc, etc.

Abbott Laboratories is a global medical equipment and healthcare company that sells medical devices, branded generic medicines, nutritional products, and diagnostics. It has research & development facilities in the United Kingdom, the United States, Spain, Singapore, India, Colombia, and China. The company markets its products in Asia-Pacific, Africa, Europe, the Middle East, Latin America, and North America, with headquarters in Abbott Park, Illinois, the United States.

Its product portfolio includes Phensedyl Cough Syrup, which is commonly used to treat chest congestion and cough.